Litcius/Paper detail

The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

Abhishek Abhishek, Sara K. Tedeschi, Tristan Pascart, Augustin Latourte, Nicola Dalbeth, Tuhina Neogi, Amy Fuller, Ann K. Rosenthal, Fabio Becce, Thomas Bardin, Hang‐Korng Ea, Georgios Filippou, John FitzGerald, Annamaria Iagnocco, Frédéric Lioté, Géraldine McCarthy, Roberta Ramonda, Pascal Richette, Francisca Sivera, Mariano Andrés, Edoardo Cipolletta, Michael Doherty, Eliseo Pascual, Fernando Pérez-Ruiz, Alexander So, Tim Jansen, Minna J. Kohler, Lisa K. Stamp, Janeth Yinh, Antonella Adinolfi, Uri Arad, Thanda Aung, Eva Benillouche, Alessandra Bortoluzzi, Jonathan Dau, Ernest Maningding, Meika A. Fang, F. Figus, Emilio Filippucci, Janine Haslett, M. Janssen, Marian Kaldas, Maryann Kimoto, Kelly Leamy, Geraldine M. Navarro, Piercarlo Sarzi‐Puttini, Carlo Alberto Scirè, Ettore Silvagni, Silvia Sirotti, John Stack, Linh Truong, Chen Xie, Chio Yokose, Alison M. Hendry, Robert Terkeltaub, William J. Taylor, Hyon K. Choi

2023Annals of the Rheumatic Diseases69 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCalcium pyrophosphateCohortRheumatologyInternal medicineDiseasePhysical therapyCalciumGout, Hyperuricemia, Uric AcidSpondyloarthritis Studies and TreatmentsRheumatoid Arthritis Research and Therapies
The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease | Litcius